✦ LIBER ✦

Immunotherapy with the use of tumor-infiltrating lymphocytes and interleukin-2 as adjuvant treatment in stage III non-small-cell lung cancer: A pilot study

✍ Scribed by Giovanni B. Ratto; Giovanni Melioli; Paolo Zino; Carlo Mereu; Sandro Mirabelli; Giovanni Fantino; Marco Ponte; Paolo Minuti; Anna Verna; Paolo Noceti; Elisabetta Tassara; Salvatore Rovida

Book ID: 114061440
Publisher: CTSNet
Year: 1995
Tongue: English
Weight: 553 KB
Volume: 109
Category: Article
ISSN: 1097-685X
DOI: 10.1016/s0022-5223(95)70205-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunotherapy with the use of tumor-infi

Immunotherapy with the use of tumor-infiltrating lymphocytes and interleukin-2 as adjuvant treatment in stage III non-small-cell lung cancer: A pilot study

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 265 KB

A randomized trial of adoptive immunothe

A randomized trial of adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 versus standard therapy in the postoperative treatment of resected nonsmall cell lung cancer

✍ Giovanni B. Ratto; Paolo Zino; Sandro Mirabelli; Paolo Minuti; Riccardo Aquilina 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 750 KB

A previous pilot study from our group suggested that: (1) adoptive immunotherapy (AI) with tumor-infiltrating lymphocytes (TIL) and recombinant interleukin-2 (rIL-2) may be applied with safety to more than 80% of the patients who had surgery for Stage 111 nonsmall cell lung carcinoma (NSCLC); and (2

Biological and clinical results of a neu

Biological and clinical results of a neuroimmunotherapy with interleukin-2 and the pineal hormone melatonin as a first line treatment in advanced non-small cell lung cancer

✍ Lissoni, P; Tisi, E; Barni, S; Ardizzoia, A; Rovelli, F; Rescaldani, R; Ballabio 📂 Article 📅 1992 🏛 Nature Publishing Group 🌐 English ⚖ 742 KB

Biological and clinical results of a neu

Biological and clinical results of a neuroimmunotherapy with interleukin-2 and the pineal hormone melatonin as a first line treatment in advanced non-small cell lung cancer

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 305 KB

Use of neuroendocrine markers, p53, and

Use of neuroendocrine markers, p53, and HER2 to predict response to chemotherapy in patients with stage III non-small cell lung cancer: a Cancer and Leukemia Group B study

✍ Graziano, Stephen L; Tatum, Arthur; Herndon, James E; Box, James; Memoli, Vincen 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 88 KB

Docetaxel and cisplatin as induction che

Docetaxel and cisplatin as induction chemotherapy in patients with pathologically-proven stage IIIA N2 non-small cell lung cancer: a phase II study of the European organization for research and treatment of cancer (EORTC 08984)

✍ B. Biesma; C. Manegold; H.J.M. Smit; L. Willems; C. Legrand; A. Passioukov; J.P. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 153 KB